Because of its dynamic structure, the omentum plays a key role in the immunity of the peritoneal cavity by orchestrating peritoneal cell recruitment. Because mast cells accumulate in the omentum upon experimental peritoneal dialysis (PD) and may produce angiogenic/profibrotic factors, it was hypothesized that mast cells mediate omental tissue remodeling during PD. Daily treatment with conventional PD fluid (PDF) for 5 wk resulted in a strong omental remodeling response, characterized by an approximately 10-fold increase in mast cell density (P < 0.01), an approximately 20-fold increase in vessel density (P < 0.02), an approximately 20-fold increase in the number of milky spots (P < 0.01), and a four-fold increase in submesothelial matrix thickness (P < 0.0003) in wild-type rats. In contrast, all PDF-induced omental changes were significantly reduced in mast cell-deficient Ws/Ws rats or in wild-type rats that were treated orally with a mast cell stabilizer cromoglycate. A time-course experiment showed mast cell accumulation immediately before the formation of blood vessels and milky spots. Functionally, PDF evoked a peritoneal cell influx, which was significantly reduced in Ws/Ws rats (P < 0.04) and in wild-type rats that were treated with cromoglycate (P < 0.03). Cromoglycate treatment also completely prevented PDF-induced omental adhesions to the catheter tip (P ‫؍‬ 0.0002). Mesothelial damage, angiogenesis, and fibrosis of mesentery and parietal peritoneum as well as glucose absorption rate and ultrafiltration capacity proved to be mast cell independent. Data strongly support the hypothesis that mast cells mediate PDF-induced omental tissue remodeling and, subsequently, peritoneal cell influx and adhesion formation, providing therapeutic possibilities of modulating omental function.
O ver several decades, omental transposition has been applied to many human disorders, resulting in an accelerated wound-healing process (1) (2) (3) (4) (5) (6) . In the tissue engineering field, new organs were developed successfully by implantation of embryonic tissues, for example kidney and pancreas, into the omentum of the recipient (7, 8) . Previously, we showed that the omentum exerts an important role in the peritoneal defense mechanism against pathogens by providing not only the primary site for neutrophil exudation but also the local site for peritoneal leukocyte proliferation and macrophage differentiation (9 -11) . Despite that this broad range of omental applications and functions is due mainly to its unique angiogenic properties, the underlying (cellular) mechanism of omental angiogenesis has not yet been identified fully.
The clinical application of peritoneal dialysis (PD) has introduced the peritoneum, including omentum, into the nephrology field. A number of research groups now are using omentum as a model for investigating various aspects of PD-related pathophysiology (12, 13) . We previously reported that longterm exposure to PD fluid (PDF) evoked a chronic inflammatory response in an animal model, which typically is associated with a rapid influx of inflammatory cells toward the peritoneal cavity, followed by angiogenesis in various peritoneal tissues, including omentum, and serosal injury to mesothelial cells that cover the peritoneum as well as fibrogenesis (14, 15) . Clinically, these pathologic alterations ultimately result in impaired ultrafiltration capacity, leading to treatment failure in a significant number of PD patients. It is interesting that we found that angiogenesis in the omentum was accompanied y the accumulation of omental mast cells, located in close contact with vessels, and their number correlated strongly to the number of omental vessels in our PD model (15, 16) . The latter also was found in other inflammatory conditions (17, 18) . To test the hypothesis that mast cells are the key cells that control PDFinduced omental tissue remodeling and, subsequently, peritoneal cell influx, we treated "white spotting" (Ws/Ws) mast cell-deficient rats and their normal ϩ/ϩ littermates with PDF daily. The Ws/Ws rats are affected by a 12-base deletion at the tyrosine kinase domain of c-kit gene (19) , which is essential not only for mast cell development but also for hematopoiesis, erythropoieses, and gametogenesis (20, 21) . The Ws/Ws rats proved to be a powerful tool to determine the definite role of mast cells in many pathologic conditions as well as in normal wound healing (22) (23) (24) (25) . In addition, we orally administered a mast cell stabilizer, disodium cromoglycate, to wild-type rats that were treated with PDF. Our data strongly indicate an essential role for mast cells in PDF-induced omental tissue remodeling and, subsequently, peritoneal cell recruitment.
Materials and Methods

Laboratory Animals
In the first experiment, we used male mast cell-deficient Ws/Ws rats and their normal wild-type littermates (Karolinska Institute, Stockholm, Sweden) that weighed 180 to 240 g at the start of the experiment. For other experiments, we used male wild-type Wistar rats (Harlan CPB, Horst, The Netherlands) that weighted 280 to 300 g at the start of the experiment. Rats were maintained under conventional laboratory conditions and were given free access to water and food. Body weights of all animals were monitored weekly, and no significant differences were found among the groups in each experiment (data not shown). Experiments were reviewed and approved by the local ethical committee on the use of laboratory animals and are in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Experimental Design
Experiment 1. Mast cell-deficient (Ws/Ws; n ϭ 10) and wild-type rats (ϩ/ϩ; n ϭ 10) were exposed daily to 10 ml of conventional PDF (Dianeal PD4, 3.86% glucose, pH 5.2; Baxter R&D, Utrecht, The Netherlands), via a permanent peritoneal catheter connected to a subcutaneous mini vascular access port (14,15) for 5 wk. Gender-and agematched untreated mast cell-deficient (n ϭ 8) and wild-type (n ϭ 12) rats served as controls. To determine peritoneal performance and total cell influx upon PDF instillation, we performed a peritoneal equilibration test (PET) after 5 wk of PDF treatment in half of the PDF-treated animals (five rats per group) as well as in all controls. A 1.5-h, PET was performed, by using 30 ml of the conventional PDF. Glucose levels were determined in PET effluents by the hexokinase method on a Roche/Hitachi (Basel, Switzerland) Modular P800, and percentage of glucose absorption was calculated as [1 Ϫ (final dialysate glucose concentration) ϫ (drained volume)/200 mM ϫ 30 ml] ϫ 100. Cell-free supernatants of PET effluents were stored at Ϫ20°C for measurement of vascular endothelial growth factor (VEGF), monocyte chemoattractant protein-1 (MCP-1), IL-1␤, and TNF-␣. Furthermore, a peritoneal wash was performed in the remaining animals in both PDF-treated groups (five rats per group), as described previously (14) . Different peritoneal tissues were collected for morphometric analysis. Experiment 2. Wild-type Wistar rats were exposed to the conventional PDF with (n ϭ 7) or without (n ϭ 8) oral disodium cromoglycate, a mast cell stabilizer, for 5 wk. The cromoglycate was dissolved in 1 ml of 95% polyethyleneglycol and administered via gavage (50 mg/kg per d). The first control group (n ϭ 8) received only the vehicle (polyethyleneglycol), whereas the second control group (n ϭ 6) received only cromoglycate orally. Thereafter, PET was performed, followed by morphologic and cellular analysis. Effectiveness of cromoglycate treatment was controlled by direct injection of 10 nmol of degranulating compound 48/80 into the right hind paw in a volume of 50 l. The same volume of vehicle was injected into the left hind paw. Degranulation of mast cells in the right hind paw resulted in paw swelling, which can be measured. Right/left paw thickness ratio was measured after 60 min and was increased from 1.01 (before injection) to 1.08 in control rats without cromoglycan. In rats that were treated with PDF ϩ cromoglycan, right/left ratio remained stable from 1.01 at baseline to 1.00 at 60 min, showing a complete prevention of mast cell-mediated right hind paw swelling by cromoglycate treatment.
Experiment 3. Omental mast cell density was quantified in several groups of Wistar rats that were exposed to conventional lactate-buffered PDF, bicarbonate/lactate-buffered PDF (Physioneal, 3.86% glucose, low glucose degradation products content, pH 7.4; Baxter R&D; n ϭ 8), or bicarbonate/lactate buffer without glucose (pH 7.4; n ϭ 7). Eight gender-and age-matched rats served as controls.
To exclude peritonitis, we checked peritoneal cell-free supernatants (obtained form peritoneal wash and PET effluents) for the presence of bacteria by agar plating, and no bacteria were found. Omental tissues also were inspected for the presence of bacteria and/or adherent neutrophils, and no bacteria or abnormal numbers of neutrophils were found. Furthermore, the well-being of all animals was monitored daily, but no apparent abnormalities were observed. Development of body weight of all animals also was normal.
Quantification of Mast cells
Omentum and Mesentery. Large whole-mount preparations of omental tissue (approximately 4 cm 2 /rat) and the mesentery (the most distally situated loop entirely) were spread on a glass slide for light microscopic examination. The sections were stained with 1% toluidine blue, and the number of mast cells was counted and expressed as the number of cells per square millimeter, using a scored eyepiece, as described previously (15, 16 
Quantification of Blood Vessels
Omentum. Two stretched preparations of the omentum (approximately 4 cm 2 /rat) were obtained for quantification of blood vessels in each rat in a standardized manner. One sample was stained with toluidine blue (14, 15) . The blood vessels per area of 4 mm 2 were counted, and 25 random areas were selected from each preparation (total 1 cm 2 ). The second sample was stained with a specific endothelial marker, anti-CD31 (platelet-endothelial cell adhesion molecule; Serotec, Oxford, UK), as described previously for parietal peritoneum (15) . Mesentery. The number of blood vessels was quantified in the mesenteric whole-mount preparations after staining with toluidine blue, as described for omentum (14, 15) .
Parietal Peritoneum. The number of blood vessels within submesothelial ECM was quantified, using anti-CD31, and expressed as the number of vessels per millimeter length of the mesothelial cell layer (15) .
Quantification of Milky Spots in Omentum
The number and the size of milky spots was determined by light microscopy using a scored eyepiece, as described previously (14, 15) . Total milky spot surface area was calculated by multiplying both parameters.
Electron Microscopy of Peritoneal Tissues
Portions of dissected omentum, mesentery, and parietal peritoneum from at least three rats per group were prepared for electron microscopy (14) . each electron micrograph, and the mean value was calculated for each micrograph. We analyzed at least three rats per group and at least 10 photomicrographs per rat and therefore at least 30 measurements per group.
Parietal Peritoneum. The thickness of the submesothelial ECM layer was determined after Van Gieson staining (Merck KGaA, Darmstadt, Germany), and the average of 10 independent measurements was calculated for each rat and expressed in microns (14, 15) .
Peritoneal Lavage Fluid
PET fluids and peritoneal washes were centrifuged, and cells were counted and differentiated according standard procedures. PET cellfree peritoneal fluids were 20 times concentrated (Amicon Ultra-4), and VEGF concentration was measured by ELISA according to the manufacturer's instruction (Quantikine M, VEGF kit; R&D Systems, Minneapolis, MN). The detection level was 15 pg/ml. MCP-1 (Pharmingen, San Diego, CA), IL-1␤, and TNF-␣ (NIBSC, South Mimms, UK) were determined by ELISA, detection level 60, 30, and 30 pg/ml, respectively.
Statistical Analyses
Data are expressed as medians and 25th to 75th interquartile ranges and the spread from 10th to 90th percentile. In case of multiple comparisons, independent groups first were analyzed statistically by nonparametric ANOVA (Kruskal-Wallis test), followed by the Mann Whitney U test, corrected according to Bonferroni (P ϭ 0.05/͌ number of comparisons). In experiment 1, four comparisons are made: (1) ϩ/ϩ rats with and without PDF, (2) Ws/Ws rats with and without PDF, (3) both untreated groups, and (4) both PDF-treated groups (P Ͻ 0.025 level of significance). In experiment 2, three comparisons are made: (1) PDF-treated rats versus control rats, (2) PDF ϩ cromoglycate-treated rats versus control rats, and (3) PDF ϩ cromoglycate-treated rats versus control rats (P Ͻ 0.03 level of significance). In experiment 3, three comparisons are made: Dianeal treated rats versus (1) physioneal-treated rats, (2) buffer-treated rats, and (3) untreated control rats (P Ͻ 0.03 level of significance). Spearman rank correlation test was used for correlation analysis, and Fisher exact test was used for analysis of contingency table.
Results
Mast Cells Mediate Omental Tissue Remodeling
Mast Cell Density. Light microscopic observation of the omentum, mesentery, and parietal peritoneum confirmed the absence of mast cells in the Ws/Ws rats before and after PDF treatment. Data from peritoneal wash also confirmed the lack of mast cells and eosinophils in the peritoneal fluid of Ws/Ws rats before and after PDF treatment. Furthermore, analysis of the peritoneal wash revealed that mast cells almost disappeared from the peritoneal cavity of ϩ/ϩ animals that were treated with PDF, whereas 5 to 7% of total peritoneal cells were mast cells in control ϩ/ϩ rats (P Ͻ 0.0005). Mast cells accumulated preferably within omental milky spots, as the number of mast cells within milky spots was approximately 10-fold higher in the ϩ/ϩ rats that were treated with PDF compared with control ϩ/ϩ rats (P Ͻ 0.005). In addition, the mast cell density was significantly increased in omental tissues between milky spots of ϩ/ϩ rats upon PDF treatment (P Ͻ 0.004; Figures 1 and 2 ). Compared with controls, rats that were exposed to PDF with or without cromoglycate also showed an increased number of mast cells within and between omental milky spots, with no significant differences between both treated groups ( Figures  1 and 2) .
Angiogenesis. Exposure to PDF induced a severe angiogenesis in the omentum of ϩ/ϩ rats (P Ͻ 0.0005; Figures 1, 3 , and 4), whereas approximately six-fold fewer blood vessels were formed in the omental tissues of Ws/Ws rats (P Ͻ 0.0001). Oral administration of cromoglycate largely prevented the PDF-induced omental angiogenesis (P Ͻ 0.03; Figures 1, 3 , and 4). When all wild-type rats from both experiments were combined, a strong correlation was found between omental blood vessels and mast cells (r ϭ 0.79; P ϭ 0.0004).
In addition to histochemical staining, CD31 staining was used to identify blood vessels more specifically (Figure 3) . The results of these two methods were consistent and showed a less Representative low-magnification light micrographs of whole-mount preparations of omental tissues after toluidine blue staining of untreated wild-type (A) and untreated mast cell-deficient Ws/Ws rats (B), as well as wild-type and mast cell-deficient Ws/Ws rats exposed to peritoneal dialysis fluid (PDF; C and D, respectively). (E) PDF-treated wild-type rats that were administered cromoglycate orally. Instillation of PDF resulted in the accumulation of mast cells, along with the induction of new blood vessels and milky spots (MS) in the omental tissues of wild-type rats (A versus C) but not of mast cell-deficient Ws/Ws rats (B versus D). In the PDF ϩ cromoglycate group (E), mast cells did accumulate; however, without the formation of new vessels and milky spots (E versus C). MS, mast cells (arrowheads), and blood vessels (arrows) are visualized clearly.
profound angiogenesis in Ws/Ws rats treated with PDF as well as in wild-type rats treated with PDF and cromoglycate, compared with ϩ/ϩ rats exposed to PDF.
Milky Spots. Instillation of PDF increased the number (P Ͻ 0.0005) and the size (P Ͻ 0.0005) of milky spots in ϩ/ϩ rats ( Figure  1 , Table 1 ). Importantly, PDF treatment induced a lower number of milky spots in the Ws/Ws rats (P Ͻ 0.0005), although the size of milky spots was equal in both PDF-treated groups (P ϭ 0.72). Compared with the PDF group, oral administration of cromoglycate significantly reduced the number of milky spots (P Ͻ 0.005), but it had no effect on the size of milky spots (P Ͼ 0.99). Correlation analysis in all wild-type rats revealed a strong positive relationship between the number of milky spots and mast cells in the omentum (r ϭ 0.78; P ϭ 0.001).
Fibrosis. Daily exposure to PDF resulted in an increased omental thickness in ϩ/ϩ rats (P Ͻ 0.003), whereas PDF did not lead to omental fibrosis in Ws/Ws rats (Figures 5 and 6 ). Oral administration of cromoglycate completely prevented the PDF-induced fibrosis in the omentum (P Ͻ 0.0001; Figures 5 and 6) . In control rats, cromoglycate alone (thus without PDF instillation) had no effect on omental mast cell density, angiogenesis, milky spot response, and fibrosis (data not shown). 
Time-Course Study
The kinetics of the PDF-mediated omental mast cell accumulation and angiogenesis was determined by exposing several groups of rats to PDF (n ϭ 2 to 4/group) for 1 to 5 wk ( Figure  7 ). Mast cells started to accumulate markedly from the third week. It is interesting that the formation of new blood vessels and milky spots started from the fourth week, whereas this was not observed in the first 3 wk. These data indicate that omental mast cells significantly increased immediately before the formation of blood vessels and milky spots.
Mast Cells Regulate Leukocyte Recruitment and Omental Adhesion Formation
Because mast cells mediated the PDF-induced omental angiogenesis and milky spot response and because milky spots reflect a functional aspect of the omentum in terms of peritoneal cell influx, we counted the number of cells in the peritoneal cavity upon PDF instillation. PDF exposure induced a significant influx of cells (Figure 8 ), mostly macrophages, into the peritoneal cavity during the PET procedure in the ϩ/ϩ (P Ͻ 0.002) and to a far lesser extent in the Ws/Ws rats (P ϭ 0.082), compared with their controls. It is interesting that more cells were recruited toward the peritoneal cavity in the ϩ/ϩ rats compared with Ws/Ws rats after pretreatment with PDF (P Ͻ 0.03). We found no significant differences in the percentage of macrophages (P ϭ 0.90), lymphocytes (P ϭ 0.73), or neutrophils (P ϭ 0.55) between both treated groups. Absolute numbers of macrophages, neutrophils, and lymphocytes all were reduced in PDF- The number of blood vessels in the omental tissues of untreated wild-type (controlϩ/ϩ) and untreated mast cell-deficient (Control Ws/Ws) rats, as well as wild-type (PDF ϩ/ϩ) and mast cell-deficient Ws/Ws rats exposed to PDF (PDF Ws/Ws). (B) We compared PDF-induced new vessel formation in wild-type Wistar rats with and without cromoglycate therapy. Note the increased number of blood vessels in wild-type rats treated with PDF, which was significantly prevented in mast cell-deficient Ws/Ws and wildtype rats treated orally with cromoglycate.
treated Ws/Ws rats, suggesting hampered peritoneal cell recruitment in general. Similar to the Ws/Ws rats, administration of cromoglycate significantly reduced PDF-induced cell influx (P Ͻ 0.03). MCP-1, a major chemoattractant for monocytes/macrophages, was significantly increased in cell-free PET fluids from all rats that were treated by PDF; however, no differences were found between PDF-treated ϩ/ϩ and Ws/Ws rats or between PDF-treated rats with or without cromoglycate (Tables 2 and 3 ). The proinflammatory cytokines IL-1␤ and TNF-␣ were below detection limits in cellfree PET fluids of all rats.
In experiment 2 (intervention with cromoglycate), when the rats were killed, we scored the presence or absence of omental adhesion formation around the catheter tip. All PDF-treated rats (n ϭ 7) showed variable omental adhesion to the catheter. In striking contrast, in none (n ϭ 8) of the PDF ϩ cromoglycate rats this was observed (Fisher exact test: P ϭ 0.0002).
Mast Cell-Dependent Omental Tissue Remodeling Is Not Related to Effluent VEGF
Daily exposure to PDF significantly increased the VEGF levels in the peritoneal effluents of both wild-type (median 46 pg/ml) and Ws/Ws rats (median 51 pg/ml), compared with control wild-type (median 16 pg/ml) and control Ws/Ws rats (median 12 pg/ml). No significant differences were found between treated ϩ/ϩ and Ws/Ws rats (P ϭ 0.69). Oral administration of cromoglycate had no effect on increased VEGF levels after PDF treatment (P ϭ 0.63).
Mast Cells Are Not Involved in Tissue Remodeling of Other Peritoneal Tissues
In contrast to the omentum, mast cells did not accumulate in the mesentery (P ϭ 0.38) or parietal peritoneum (P ϭ 0.90) of ϩ/ϩ rats upon PDF exposure (Tables 2 and 3) . A similar number of blood vessels were formed in the mesentery (P Ͼ 0.99) and parietal peritoneum (P ϭ 0.19) of PDF-exposed Ws/Ws and ϩ/ϩ rats as well as cromoglycate-treated rats (Tables 2 and  3) . Furthermore, the number of blood vessels did not correlate to the number of mast cells in the mesentery (r ϭ 0.02; P ϭ 0.96) or in the parietal peritoneum (r ϭ 0.10; P ϭ 0.86). No differences were found between ϩ/ϩ and Ws/Ws rats after treatment with PDF with respect to fibrosis (Tables 2 and 3) in the mesentery (P ϭ 0.25) or parietal peritoneum (P ϭ 0.54). In addition, cromoglycate did not reduce PDF-induced fibrosis in the mesenteric tissues (P ϭ 0.11) or in parietal peritoneum of Wistar rats (P ϭ 0.13).
Mast Cells Are Not Involved in PDF-Induced Mesothelial Cell Injury
Compared with controls, exposure to PDF resulted in a strong regenerative response of mesothelial cells on liver in both ϩ/ϩ (P Ͻ 0.0003; Tables 2 and 3) and Ws/Ws rats (P Ͻ 0.009), without significant difference between both treated groups (P ϭ 0.63). Cromoglycate had no impact on PDF-induced mesothelial regenerative response (data not shown). Using electron microscopy, we observed focal damage to the mesothelial cell layer covering the omentum (Figure 5 ), mesentery, and parietal peritoneum in both ϩ/ϩ and Ws/Ws rats after exposure to PDF, as well as in the cromoglycate-treated rats, along with adhesion of macrophages, with no difference among treated groups.
Mast Cells Are Not Involved in Microvascular Peritoneal Transport
Chronic exposure to PDF was associated with loss of ultrafiltration capacity (Tables 2 and 3) , accompanied by increased glucose absorption from peritoneal cavity, in both ϩ/ϩ and Ws/Ws rats compared with control rats, without significant differences between both treated groups with respect to ultrafiltration capacity (P ϭ 0.41) or glucose absorption rate (P ϭ 0.19), although ultrafiltration capacity and glucose absorption seem to be somewhat lower in the Ws/Ws strain. Oral administration of cromoglycate had no significant impact on PDFinduced ultrafiltration dysfunction (P ϭ 0.10) or on the increased glucose reabsorption (P ϭ 0.12). c Differs from mast cell-deficient rats that were exposed to PDF: P Ͻ 0.0005. d Differs from Wistar rats that were exposed to PDF ϩ cromoglycate: P Ͻ 0.02.
Less Profound Mast Cell Accumulation upon Treatment with Bicarbonate/Lactate-Buffered PDF
Increased mast cell accumulation upon treatment with lactate-buffered PDF was significantly reduced after exposure to bicarbonate/lactate-buffered PDF or the buffer alone (Figure 9 ).
The data presented here are in good agreement with our earlier data showing a milder omental tissue remodeling after treatment with the bicarbonate/lactate-buffered PDF and the buffer alone (14, 26) .
Discussion
In this report, we provide evidence for the critical involvement of mast cells in PDF-induced omental tissue remodeling and, subsequently, peritoneal cell influx and omental catheter adhesion during experimental PD. We previously showed that omental milky spots are active sites for leukocyte migration Figure 5 . Transmission electron microscopy of omental tissues. Representative images are shown from an untreated wild-type rat (A) as well as a PDF-treated wild-type rat (B), a PDF-treated mast cell-deficient Ws/Ws rat (C), and a PDF-treated wild-type rat administrated with cromoglycate orally (D). Note a significant increase in the thickness of the omentum from wild-type rats that were treated with PDF (B), which was completely prevented in PDF-treated mast cell-deficient Ws/Ws rats (C) or PDF-treated wild-type rats ϩ cromoglycate (D). Original magnification: ϫ3000. Figure 6 . Measurement of omental fibrosis. Thickness of the submesothelial extracellular matrix layer measured in electron microscopy photomicrographs of untreated wild-type (Control ϩ/ϩ) and untreated mast cell-deficient (Control Ws/Ws) rats compared with PDF treatment in these rats (A). (B) We compared PDF-induced fibrosis in wild-type rats with and without cromoglycate therapy. Note the increased matrix layer in wild-type rats that were treated with PDF, which was completely prevented in mast cell-deficient Ws/Ws and wild-type rats that were treated orally with cromoglycate. and peritoneal leukocyte supply during inflammation (9 -11). In addition, milky spots are the sites for local proliferation, maturation, and differentiation of macrophages (10) . It has been reported that the inherited mast cell deficiency in experimental peritonitis models significantly impaired the cell influx (27, 28) ; however, no explanation was provided. Jippo et al. (29) elegantly showed that tissue mast cells, not those in the peritoneal fluid, are essential for a proper innate immunity against bacterial invasion. In agreement with these studies, we observed that the PDF-induced cell influx was significantly reduced in Ws/Ws rats or in wild-type rats that were treated with cromoglycate. Along with a poor cell influx, Ws/Ws rats and rats that were treated with cromoglycate developed a weak milky spot response, which might explain the poor influx response that was found in mast cell-deficient rats in this study and during peritonitis (27, 28) . We therefore suggest a novel role for mast cells in the induction of a proper omental milky spot response, providing new opportunities to regulate peritoneal cell recruitment. Formally, we cannot exclude the possibility that a reduced peritoneal cell recruitment in mast cell-deficient rats results in a hampered omental tissue remodeling. However, the absence of the proinflammatory mediators IL-1␤ and TNF-␣ do not support the idea that these exudate cells actively influence tissue remodeling.
A better understanding of how mast cells participate in omental angiogenesis is critical to increase our knowledge about vascular dysfunction and tissue remodeling. Several lines of evidence suggest a key role for mast cells in the induction of angiogenesis. Mast cells often are found near blood vessels and accumulate in various pathologic conditions (30 -33) . There is a significant correlation between mast cell numbers and blood vessel density in different kinds of cancer (34) and in this study. Most important, mast cells are able to produce and release many potent angiogenic factors, including tryptase, chymase, VEGF, basic fibroblast growth factor, and IL-8 (35) . Similar to the chick chorioallantoic membrane model for angiogenesis (36) , our time-course study revealed an increased number of mast cells immediately before the formation of new blood vessels. It is interesting that the inhibition of PDFinduced omental angiogenesis did not improve the ultrafiltration capacity and glucose absorption, confirming the idea that the transport function of the peritoneum is dominated by blood vessels of the parietal peritoneum.
At this time, we do not know which mast cell mediator(s) is(are) We compared PDF-induced cell influx in wild-type rats with and without cromoglycate therapy. Note a strong cell influx to ward the peritoneal cavity in wild-type rats treated with PDF, which was significantly prevented in mast cell-deficient Ws/Ws and wildtype rats treated orally with cromoglycate.
involved in omental remodeling during PD. That therapeutic intervention using cromoglycate yielded exactly the same results as using mast cell-deficient rats clearly indicates mast cell degranulation to be essential for the observed response and excludes a delayed mast cell response via de novo synthesis of inflammatory mediators. In contrast to an earlier report (37), we found no role for VEGF in the omental tissue remodeling, because an equal amount of VEGF was released into the peritoneal cavity of wildtype and mast cell-deficient rats after PDF treatment, which could be explained by the fact that VEGF is not stored in mast cell granules (38) . Nevertheless, we cannot exclude the possibility that VEGF concentration at the tissue level might be different between both treated groups. Mast cells also participate in fibrotic processes (39) . Mast cells are found in fibrogenic lesions in various diseases and contain potent profibrotic mediators. Using mast cell-deficient animals, some studies showed no difference in the degree of fibrosis between mast cell-deficient and ϩ/ϩ animals (23,40), whereas other studies suggested a key role for mast cells in this process (41) . These seemingly opposing results are reflected nicely in our study, in which we show omental fibrosis to be mast cell dependent, whereas the fibrotic response in the mesentery and parietal peritoneum is mast cell unrelated. The complete absence of omental adhesion formation to the catheter tip in the PDF ϩ cromoglycan group is in striking contrast to the 100% presence of these adhesions in the PDF group. This might be a clinically important observation that warrants further investigation. The role of mast cells in adhesion formation had been documented (42) .
To our knowledge, this study is the first to unravel the underlying cellular regulatory mechanism of omental tissue remodeling, which is responsible for the recruitment of inflammatory cells during PD. We therefore propose that PDF activates omental endothelium to promote the adhesion and migration of leukocytes, including mast cells. We indeed have shown by electron microscopy an activated high endothelial venule-like phenotype of endothelial cells within milky spot vessels upon PDF instillation (14) . In addition, we previously reported an increased number of rolling leukocytes in peritoneal venules of PDF-treated rats, pointing toward endothelial activation (43) . Once migrated, these recruited perivascular (mast) cells stay around vessels and do not migrate toward the peritoneal cavity but rather form a new milky spot. This explains the accumulation of mast cells in the omentum (especially in the milky spots) and the absence of mast cells in the peritoneal fluid. These perivascular mast cells locally degranulate and thereby promote new vessel formation and fibrosis. As long as peritoneal exposure to PDF is present, this omental remodeling will continue. As soon as the trigger stops (peritoneal rest), the whole omental tissue remodeling response reverses to normal, as we recently reported (44) . Importantly, the use of bicarbonate/ lactate-buffered PDF resulted in a less profound mast cell accumulation, along with less omental remodeling, which might be clinically relevant. We believe that increasing our knowledge of omental cell biology, especially the critical role of mast cells therein, will provide new opportunities to regulate omental function not only during PD treatment but also during chirurgical omental transposition, tissue engineering, peritoneal defense, adhesion formation, and tumor growth. Less profound omental mast cell accumulation upon exposure to bicarbonate/lactate-buffered PD solution. Mast cell density (number of cells/mm 2 ) counted in omental tissues between the MS from wild-type rats exposed to conventional lactate-buffered PDF (ConPDF), bicarbonate/lactate-buffered PDF (Bic/Lac), or bicarbonate/lactate buffer without glucose, as well as untreated control rats (C). The number of mast cells in the ConPDF group was significantly increased compared with all other groups (P Ͻ 0.002). The number of mast cells also was increased in the Bic/lac (P Ͻ 0.002) and the buffer group (P Ͻ 0.003), compared with control rats.
